Analysis of Factors Contributing to Antenatal Corticosteroid Administration in Threatened Preterm Labor

dc.contributor.authorBode, Leah
dc.contributor.authorMcKinzie, Alexandra
dc.contributor.authorGidia, Nadia
dc.contributor.authorIbrahim, Sherrine
dc.contributor.authorHaas, David
dc.date.accessioned2024-06-14T13:26:48Z
dc.date.available2024-06-14T13:26:48Z
dc.date.issued2023-05
dc.description.abstractINTRODUCTION: Antenatal corticosteroids (ACS) are recommended for pregnant persons at risk for imminent preterm delivery within 7 days. Many diagnosed with threatened preterm labor (tPTL) are given ACS but do not deliver until term. The objective of this study was to analyze characteristics of those seen for tPTL who receive ACS to better understand clinical decision-making. METHODS: This retrospective cohort study consisted of patients seen in triage at an urban hospital caring for underserved patients in 2021 for tPTL during pregnancy. Demographic variables (maternal age, race and ethnicity, prior preterm delivery) and obstetric variables (cervical dilation, effacement, membrane rupture, tocolytic administration) were evaluated against the primary outcome of ACS administration. RESULTS: Two hundred ninety pregnant people with 372 unique encounters for tPTL were identified. The mean gestational age at presentation was 33.5 weeks. 107 patients in 111 encounters received ACS, which was associated with lower body mass index (BMI), greater cervical dilation and effacement, membrane rupture, and more frequent contractions (all P<.01). Logistic regression, limited to first encounter in triage, found that BMI (odds ratio 0.91, 95% CI 0.87–0.95), cervical dilation 2 cm or greater (2.49, 1.12–5.35), and cervical effacement 50% or higher (4.80, 2.25–10.24) were significantly associated with patients receiving ACS. Forty-four percent of those receiving ACS delivered within 7 days, compared to 11% of those who did not receive ACS (P<.001). CONCLUSION: Greater cervical dilation and effacement and a lower BMI were associated with ACS administration, although most patients receiving ACS did not deliver within 7 days. These findings will contribute to developing a clinical decision model for administering ACS.
dc.identifier.citationAnalysis of Factors Contributing to Antenatal Corticosteroid Administration in Threatened Preterm Labor: Correction. Obstetrics & Gynecology 143(3):p e89, March 2024. DOI: 10.1097/AOG.0000000000005507 Haas D, Gidia N, Ibrahim S, McKinzie A. Analysis of factors contributing to antenatal corticosteroid administration in threatened preterm labor. Obstet Gynecol 2023;141:25–6S. doi: 10.1097/01.aog.0000930032.98040.29
dc.identifier.urihttps://hdl.handle.net/1805/41556
dc.language.isoen_US
dc.publisherWolters Kluwer Health, Inc.
dc.relation.isversionof10.1097/AOG.0000000000005507
dc.subjectAntenatal
dc.subjectAntenatal corticosteroids
dc.subjectPreterm steroids
dc.subjectThreatened preterm labor
dc.subjectPPROM
dc.titleAnalysis of Factors Contributing to Antenatal Corticosteroid Administration in Threatened Preterm Labor
dc.typePoster
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bode Haas ACOG ACSM 2023 poster.pdf
Size:
374.74 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: